Skip to main content
Erschienen in: General Thoracic and Cardiovascular Surgery 6/2023

28.12.2022 | Original Article

A comparative analysis of segmentectomy-aswere medicated withinsociated factors influencing bronchial tortuosity in early-stage left upper lung cancer

verfasst von: Keigo Okamoto, Takuya Shiratori, Yo Kawaguchi, Yasuhiko Ohshio, Jun Hanaoka

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Several studies of early-stage non-small cell lung cancer (NSCLC) have reported a notable therapeutic effect of segmentectomy. However, the secondary benefits of lung volume preservation remain unclear. This study aimed to investigate the potential benefits of segmentectomy, in terms of its impact on postoperative bronchial change.

Methods

Patients who underwent left-sided upper lobectomy and upper division segmentectomy for pStage 0-IA2 NSCLC, were retrospectively analyzed. Degree of the left main bronchial deviation was measured by the curvature index (CI), determined using computed tomography. Variables, including CI value and postoperative rate of change in CI were compared for postoperative cough management the lobectomy and segmentectomy groups.

Results

Sixty-seven patients were reviewed. Thirty-seven and 30 patients underwent lobectomy and segmentectomy, respectively, without any significant differences in baseline and surgical variables. The 5-year overall survival rates in the lobectomy and segmentectomy groups were 86.7 and 95.2%, respectively (p = 0.437). While there was no significant difference in postoperative complications, the rate of change in CI was significantly higher in the lobectomy group than in the segmentectomy group (113 vs. 106%, p = 0.005). In addition, the analysis based on postoperative cough reveals the rate of change in CI to be significantly higher in patients requiring medical treatment (p = 0.005).
Conclusions Left upper division segmentectomy provides satisfactory treatment and relief of postoperative bronchial tortuosity. Our study suggests that there is a possibility the mitigation of environmental changes in the thoracic cavity may reduce symptoms, thus contributing to an improved quality of life.
Literatur
1.
Zurück zum Zitat Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–19.CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–19.CrossRefPubMed
2.
Zurück zum Zitat Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K, et al. Japan Lung Cancer Surgical Study Group (JCOG LCSSG). A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011; 6: 751–6. Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K, et al. Japan Lung Cancer Surgical Study Group (JCOG LCSSG). A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol. 2011; 6: 751–6.
3.
Zurück zum Zitat Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al.. West Japan oncology group and Japan clinical oncology group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): aAmulticentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022; 399: 1607–17. Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al.. West Japan oncology group and Japan clinical oncology group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): aAmulticentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022; 399: 1607–17.
4.
Zurück zum Zitat Onaitis MW, Furnary AP, Kosinski AS, Feng L, Boffa D, Tong BC, et al. Equivalent survival between lobectomy and segmentectomy for clinical stage IA lung cancer. Ann Thorac Surg. 2020;110:1882–91.CrossRefPubMed Onaitis MW, Furnary AP, Kosinski AS, Feng L, Boffa D, Tong BC, et al. Equivalent survival between lobectomy and segmentectomy for clinical stage IA lung cancer. Ann Thorac Surg. 2020;110:1882–91.CrossRefPubMed
5.
Zurück zum Zitat Okamoto K, Hanaoka J. The outcome and surgical strategy of segmentectomy for c-T1 lung cancer. Kyobu Geka. 2019;72:550–3.PubMed Okamoto K, Hanaoka J. The outcome and surgical strategy of segmentectomy for c-T1 lung cancer. Kyobu Geka. 2019;72:550–3.PubMed
6.
Zurück zum Zitat Okamoto K, Hanaoka J. Surgical outcome of combined subsegmentectomy in the right upper lobe for GGO -dominant early stage lung cancer: Analysis of 7 cases. Respir Med Case Rep. 2018;26:123–5.PubMedPubMedCentral Okamoto K, Hanaoka J. Surgical outcome of combined subsegmentectomy in the right upper lobe for GGO -dominant early stage lung cancer: Analysis of 7 cases. Respir Med Case Rep. 2018;26:123–5.PubMedPubMedCentral
7.
Zurück zum Zitat Okamoto K, Kaku R, Oshio Y, Hanaoka J. Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy. Asian Cardiovasc Thorac Ann. 2022;18:2184923221081701. Okamoto K, Kaku R, Oshio Y, Hanaoka J. Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy. Asian Cardiovasc Thorac Ann. 2022;18:2184923221081701.
8.
Zurück zum Zitat Seok Y, Cho S, Lee JY, Yang HC, Kim K, Jheon S. The effect of postoperative change in bronchial angle on postoperative pulmonary function after upper lobectomy in lung cancer patients. Interact Cardiovasc Thorac Surg. 2014;18:183–8.CrossRefPubMed Seok Y, Cho S, Lee JY, Yang HC, Kim K, Jheon S. The effect of postoperative change in bronchial angle on postoperative pulmonary function after upper lobectomy in lung cancer patients. Interact Cardiovasc Thorac Surg. 2014;18:183–8.CrossRefPubMed
9.
Zurück zum Zitat Lin R, Chen W, Zhu L, Pan X. Comparison of postoperative cough-related quality of life and recovery between sublobectomy and lobectomy for early-stage non-small cell lung cancer patients: a longitudinal study. BMC Pulm Med. 2022;22:154.CrossRefPubMedPubMedCentral Lin R, Chen W, Zhu L, Pan X. Comparison of postoperative cough-related quality of life and recovery between sublobectomy and lobectomy for early-stage non-small cell lung cancer patients: a longitudinal study. BMC Pulm Med. 2022;22:154.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Moon DH, Park CH, Jung JH, Kim TH, Haam SJ, Lee S. Inferior pulmonary ligament division may be unnecessary during left upper lobectomy: Effects on lung volume, bronchial angle and bronchial tortuosity. J Clin Med. 2021;10:4033.CrossRefPubMedPubMedCentral Moon DH, Park CH, Jung JH, Kim TH, Haam SJ, Lee S. Inferior pulmonary ligament division may be unnecessary during left upper lobectomy: Effects on lung volume, bronchial angle and bronchial tortuosity. J Clin Med. 2021;10:4033.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Huang CY, Hsieh MS, Wu YK, Hsieh PC, Yang MC, Tzeng IS, et al. Chronic obstructive pulmonary disease assessment test for the measurement of deterioration and recovery of health status of patients undergoing lung surgery. Thorac Cancer. 2022;4:613–23.CrossRef Huang CY, Hsieh MS, Wu YK, Hsieh PC, Yang MC, Tzeng IS, et al. Chronic obstructive pulmonary disease assessment test for the measurement of deterioration and recovery of health status of patients undergoing lung surgery. Thorac Cancer. 2022;4:613–23.CrossRef
12.
Zurück zum Zitat Dai W, Chang S, Pompili C, Qiu B, Wei X, Mu Y, et al. Early postoperative patient-reported outcomes after thoracoscopic segmentectomy versus lobectomy for small-sized peripheral non-small-cell lung cancer. Ann Surg Oncol. 2022;29:547–56.CrossRefPubMed Dai W, Chang S, Pompili C, Qiu B, Wei X, Mu Y, et al. Early postoperative patient-reported outcomes after thoracoscopic segmentectomy versus lobectomy for small-sized peripheral non-small-cell lung cancer. Ann Surg Oncol. 2022;29:547–56.CrossRefPubMed
13.
Zurück zum Zitat Paul S, Altorki NK, Sheng S, Lee PC, Harpole DH, Onaitis MW, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg. 2010;139:366–78.CrossRefPubMed Paul S, Altorki NK, Sheng S, Lee PC, Harpole DH, Onaitis MW, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg. 2010;139:366–78.CrossRefPubMed
14.
Zurück zum Zitat Ueda K, Tanaka T, Hayashi M, Tanaka N, Li TS, Hamano K. Clinical ramifications of bronchial kink after upper lobectomy. Ann Thorac Surg. 2012;93:259–65.CrossRefPubMed Ueda K, Tanaka T, Hayashi M, Tanaka N, Li TS, Hamano K. Clinical ramifications of bronchial kink after upper lobectomy. Ann Thorac Surg. 2012;93:259–65.CrossRefPubMed
15.
Zurück zum Zitat Yanagihara T, Sekine Y, Sugai K, Kawamura T, Maki N, Saeki Y, et al. Risk factors of middle lobe bronchus kinking following right upper lobectomy. J Thorac Dis. 2021;13:3010–20.CrossRefPubMedPubMedCentral Yanagihara T, Sekine Y, Sugai K, Kawamura T, Maki N, Saeki Y, et al. Risk factors of middle lobe bronchus kinking following right upper lobectomy. J Thorac Dis. 2021;13:3010–20.CrossRefPubMedPubMedCentral
Metadaten
Titel
A comparative analysis of segmentectomy-aswere medicated withinsociated factors influencing bronchial tortuosity in early-stage left upper lung cancer
verfasst von
Keigo Okamoto
Takuya Shiratori
Yo Kawaguchi
Yasuhiko Ohshio
Jun Hanaoka
Publikationsdatum
28.12.2022
Verlag
Springer Nature Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 6/2023
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-022-01900-9

Weitere Artikel der Ausgabe 6/2023

General Thoracic and Cardiovascular Surgery 6/2023 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.